Author: Monika Sims

An Update on the Burn Pits Accountability Act of 2019

an-update-on-the-burn-pits-accountability-act-of-2019

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted […]

Make an Impact from Home, 7/23!

make-an-impact-from-home,-7/23!

On July 23, over 130 advocates will meet with elected officials on Capitol Hill to advocate for the lung cancer community at the GO2 Foundation National Advocacy Summit. Now you have the opportunity to strengthen the collective voice and ignite change—without leaving your home! Join us on July 23 for […]

The 411: How Music Therapy Can Be Part Of Your Cancer Care

the-411:-how-music-therapy-can-be-part-of-your-cancer-care

Here’s a good reason to tune in: music therapy can have a positive impact on your cancer care plan. We asked SarahRose Black, an accredited music therapist and registered psychotherapist to weigh in on all the benefits that music can bring no matter what age or stage you’re at in […]

Going the Extra Mile: Jason’s Story

going-the-extra-mile:-jason’s-story

Losing a loved one to lung cancer is a pain that no one should have to experience. After Jason’s mother passed away from lung cancer in May 2018, he committed to doing something positive in her honor. On November 3, he’ll be running in the 2019 New York City Marathon as […]

New Treatment Approved for Metastatic Small Cell Lung Cancer

new-treatment-approved-for-metastatic-small-cell-lung-cancer

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for […]